Merit Medical Systems, manufacturer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, acquired DFINE in a merger transaction for ~US $97.5MM in cash.
DFINE’s products, which are FDA-cleared and approved under the CE Mark, support vertebral augmentation (kyphoplasty and vertebroplasty), as well as radiofrequency ablation of metastatic spinal tumors. For 2015, the company posted revenues of $33.4MM (75% U.S., 25% ex-U.S.).
Merit intends to create a new interventional oncology and spine division.
In early 2013, DFINE had launched StabiliT® ERX Bone Cement for use with the StabiliT® Vertebral Augmentation System for the repair of vertebral compression fractures resulting from instability. Within the same month, the company also announced a 3-year exclusive agreement with Biomet for distribution of StabiliTin Spain and Portugal.
Sources: Merit Medical Systems, Inc.; ORTHOWORLD Inc.
Merit Medical Systems, manufacturer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, acquired DFINE in a merger transaction for ~US $97.5MM in cash.
DFINE’s products, which are FDA-cleared and approved under the CE Mark, support vertebral augmentation (kyphoplasty and vertebroplasty), as well...
Merit Medical Systems, manufacturer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, acquired DFINE in a merger transaction for ~US $97.5MM in cash.
DFINE’s products, which are FDA-cleared and approved under the CE Mark, support vertebral augmentation (kyphoplasty and vertebroplasty), as well as radiofrequency ablation of metastatic spinal tumors. For 2015, the company posted revenues of $33.4MM (75% U.S., 25% ex-U.S.).
Merit intends to create a new interventional oncology and spine division.
In early 2013, DFINE had launched StabiliT® ERX Bone Cement for use with the StabiliT® Vertebral Augmentation System for the repair of vertebral compression fractures resulting from instability. Within the same month, the company also announced a 3-year exclusive agreement with Biomet for distribution of StabiliTin Spain and Portugal.
Sources: Merit Medical Systems, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.